Literature DB >> 29707367

Urokinase application for hemothorax in pulmonary mucormycosis.

Lucas Hodel1, Ilhan Inci1, Urs Schanz2, Bart Vrugt3, Walter Weder1, Sven Hillinger1.   

Abstract

We present an exemplary case of an immunocompromised patient with pulmonary mucormycosis successfully treated by a combination of surgical removal of the mucor and urokinase to control the recurring hemothorax. The use of urokinase in hemothoraces is a way to reduce repetitive surgeries in weak patients.

Entities:  

Keywords:  Hemothorax; leukemia; pulmonary mucormycosis

Year:  2018        PMID： 29707367      PMCID： PMC5906227          DOI： 10.21037/jtd.2018.03.01

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  10 in total

1.  Different microbiological and clinical aspects of lower respiratory tract infections between China and European/American countries.

Authors:  Xin Zhang; Rui Wang; Xiuzhen Di; Bin Liu; Youning Liu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

Review 2.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 3.  Mucormycosis: New Developments into a Persistently Devastating Infection.

Authors:  François Danion; Claire Aguilar; Emilie Catherinot; Alexandre Alanio; Susan DeWolf; Olivier Lortholary; Fanny Lanternier
Journal:  Semin Respir Crit Care Med       Date:  2015-09-23       Impact factor: 3.119

4.  Intrapleural Fibrinolytic Therapy for Residual Coagulated Hemothorax After Lung Surgery.

Authors:  Dayu Huang; Deping Zhao; Yiming Zhou; Hongchen Liu; Xiaofeng Chen
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

Review 5.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Evaluation of chest tube administration of tissue plasminogen activator to treat retained hemothorax.

Authors:  P J Stiles; Rachel M Drake; Stephen D Helmer; Paul M Bjordahl; James M Haan
Journal:  Am J Surg       Date:  2014-01-04       Impact factor: 2.565

7.  Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre.

Authors:  M-L Chretien; C Legouge; P-B Pagès; I Lafon; E Ferrant; A Plocque; C Favennec; L Estivalet; E Bottolier-Lemallaz; F Dalle; J-N Bastie; A Bernard; D Caillot
Journal:  Clin Microbiol Infect       Date:  2016-01-22       Impact factor: 8.067

Review 8.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Intrapleural fibrinolytic treatment of traumatic clotted hemothorax.

Authors:  I Inci; C Ozçelik; R Ulkü; A Tuna; N Eren
Journal:  Chest       Date:  1998-07       Impact factor: 9.410
  10 in total
  1 in total

1.  [Mucormycosis in patients with hematological diseases: seven cases reports and literature review].

Authors:  Y Qi; M F Zhao; Q Deng; L Geng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.